Roivant Sciences Ltd (ROIV)
Debt-to-equity ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 4,687,600 | 5,189,470 | 5,580,040 | 5,435,310 | 5,968,580 | 6,089,760 | 948,534 | 910,730 | 1,157,770 | 955,520 | 1,160,600 | 1,384,110 | 2,038,940 | 2,247,260 | 2,038,020 | 1,723,120 | 1,797,790 | — |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
March 31, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $4,687,600K
= 0.00
The debt-to-equity ratio for Roivant Sciences Ltd has been consistently at 0.00 since December 31, 2020, and has remained at this level through March 31, 2025. This indicates that the company has no debt relative to its equity during this period. A debt-to-equity ratio of 0.00 signifies that the company is primarily financed by equity rather than debt, which could be a positive sign for investors as it suggests lower financial risk and greater stability. Roivant Sciences Ltd's consistent 0.00 debt-to-equity ratio over the years implies a strong financial position and prudent capital structure management.
Peer comparison
Mar 31, 2025